ARTEMIS-103: Phase 1b Study of HS-20093 Combinations in Patients with Bone and Soft Tissue Sarcoma.
Hansoh BioMedical R&D Company
Hansoh BioMedical R&D Company
Grupo Espanol de Investigacion en Sarcomas
OHSU Knight Cancer Institute
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
OHSU Knight Cancer Institute
GlaxoSmithKline
National Cancer Institute (NCI)
National Cancer Institute (NCI)